Viscoelasticity and Ultrastructure in Coagulation and Inflammation: Two Diverse Techniques, One Conclusion

Inflammation

Volumn 38, Issue 4, 2015, Pages 1707-1726

  Swanepoel, Albe C ^a   Nielsen, Vance G ^b   Pretorius, Etheresia ^a  

^a UNIVERSITY OF PRETORIA   (South Africa)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

coagulation; fibrinogen fibrin; inflammation; morphology; platelets

Indexed keywords

BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 11A; BLOOD CLOTTING FACTOR 13; BLOOD CLOTTING FACTOR 13A; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9A; CALCIUM; FIBRIN; FIBRIN MONOMER; FIBRINOGEN; THROMBIN; THROMBOPLASTIN;

ARTICLE; BLOOD CLOTTING; CELL ULTRASTRUCTURE; FEEDBACK SYSTEM; FIBRIN FORMATION; HEMOSTASIS; INFLAMMATION; MEGAKARYOCYTE; SCANNING ELECTRON MICROSCOPY; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOCYTE STRUCTURE; THROMBOELASTOGRAPHY; VISCOELASTICITY; ANIMAL; BLOOD VISCOSITY; ELASTICITY; HUMAN; METABOLISM; PATHOLOGY; PHYSIOLOGY; PROCEDURES;

ANIMALS; BLOOD COAGULATION; BLOOD PLATELETS; BLOOD VISCOSITY; ELASTICITY; FIBRIN; HUMANS; INFLAMMATION; MICROSCOPY, ELECTRON, SCANNING; PLATELET ACTIVATION; THROMBELASTOGRAPHY;

EID: 84937253753     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-015-0148-7     Document Type: Article

References (198)

1. Gasparyan, A.Y., L. Ayvazyan, H. Blackmore, and G.D. Kitas. 2011. Writing a narrative biomedical review: Considerations for authors, peer reviewers, and editors. Rheumatology International 31(11): 1409–1417.
2. Owen, C.A. (2001) A history of blood coagulation. In: W.L. Nichols & E.J.W. Bowie (eds) Mayo Foundation for Medical Education and Research, Rochester, pp 169–180.
3. Connor, W.E. 1958. The chemistry of blood coagulation. A.M.A. Archives of Internal Medicine 102(4): 681–682.
4. Brewer, D.B. 2006. Max Schultze (1865), G. Bizzozero (1882) and the discovery of the platelet. British Journal of Haematology 133(3): 251–258.
5. Ribatti, D., and E. Crivellato. 2007. Giulio Bizzozero and the discovery of platelets. Leukemia Research 31(10): 1339–1341.
6. Dahlbäck, B. 2000. Blood coagulation. Lancet 355(9215): 1627–1632.
7. Norris, L.A. 2003. Blood coagulation. Best Practice and Research: Clinical Obstetrics and Gynaecology 17(3): 369–383.
8. Davie, E.W. 1995. Biochemical and molecular aspects of the coagulation cascade. Thrombosis and Haemostasis 74(1): 1–6.
9. Macfarlane, R.G. 1964. An enzyme cascade in the blood clotting mechanism, and its function as a biochemical amplifier. Nature 202(4931): 498–499.
10. Monroe, D.M., H.R. Roberts, and M. Hoffman. 1994. Platelet procoagulant complex assembly in a tissue factor-initiated system. British Journal of Haematology 88(2): 364–371.
11. Hoffman, M., D.M. Monroe, J.A. Oliver, and H.R. Roberts. 1995. Factors IXa and Xa play distinct roles in tissue factor-dependent initiation of coagulation. Blood 86(5): 1794–1801.
12. Monroe, D.M., M. Hoffman, and H.R. Roberts. 1996. Transmission of a procoagulant signal from tissue factor-bearing cells to platelets. Blood Coagulation and Fibrinolysis 7(4): 459–464.
13. Pérez-Gómez, F., and R. Bover. 2007. The new coagulation cascade and its possible influence on the delicate balance between thrombosis and hemorrhage. La nueva cascada de la coagulación y su posible influencia en el difícil equilibrio entre trombosis y hemorragia. Revista Espanola de Cardiologia 60(12): 1217–1219.
14. Hoffman, M., and D.M. Monroe. 2007. Coagulation 2006: a modern view of hemostasis. Hematology/Oncology Clinics of North America 21(1): 1–11.
15. Smith, S.A. 2009. The cell-based model of coagulation: State-of-the-art review. Journal of Veterinary Emergency and Critical Care 19(1): 3–10.
16. Hornyak, T.J., and J.A. Shafer. 1991. Role of calcium ion in the generation of factor XIII activity. Biochemistry 30(25): 6175–6182.
17. Adany, R., and H. Bardos. 2003. Factor XIII subunit A as an intracellular transglutaminase. Cellular and Molecular Life Sciences CMLS 60(6): 1049–1060.
18. Janus, T.J., S.D. Lewis, L. Lorand, and J.A. Shafer. 1983. Promotion of thrombin-catalyzed activation of factor XIII by fibrinogen. Biochemistry 22(26): 6269–6272.
19. Hoffman, M. 2003. Remodeling the blood coagulation cascade. Journal of Thrombosis and Thrombolysis 16(1–2): 17–20.
20. Hoffman, M., and D.M. Monroe Iii. 2001. A cell-based model of hemostasis. Thrombosis and Haemostasis 85(6): 958–965.
21. Campbell, R.A., K.A. Overmyer, C.H. Selzman, B.C. Sheridan, and A.S. Wolberg. 2009. Contributions of extravascular and intravascular cells to fibrin network formation, structure, and stability. Blood 114(23): 4886–4896.
22. Mann, K.G. 1993. Introduction: Blood coagulation. Methods in Enzymology 222: 1–10.
23. Furie, B., and B.C. Furie. 1992. Molecular and cellular biology of blood coagulation. New England Journal of Medicine 326(12): 800–806.
24. Kirchhofer, D., and Y. Nemerson. 1996. Initiation of blood coagulation: the tissue factor/factor VIIa complex. Current Opinion in Biotechnology 7(4): 386–391.
25. Mann, K.G., C. Van’t Veer, K. Cawthern, and S. Butenas. 1998. The role of the tissue factor pathway in initiation of coagulation. Blood Coagulation and Fibrinolysis 9(SUPPL. 1): S3–S7.
26. Hoffman, M., D.M. Monroe, and H.R. Roberts. 1996. Cellular interactions in hemostasis. Haemostasis 26(SUPPL. 1): 12–16.
27. Zwaal, R.F.A., P. Comfurius, and E.M. Bevers. 1998. Lipid–protein interactions in blood coagulation. Biochimica et Biophysica Acta - Reviews on Biomembranes 1376(3): 433–453.
28. Sadler, J.E. 1998. Biochemistry and genetics of von Willebrand factor. Annual Review of Biochemistry 67: 395–424.
29. Gailani, D., and G.J. Broze Jr. 1991. Factor XI activation in a revised model of blood coagulation. Science 253(5022): 909–912.
30. Lammle, B., W.A. Wuillemin, I. Huber, M. Krauskopf, C. Zurcher, R. Pflugshaupt, and M. Furlan. 1991. Thromboembolism and bleeding tendency in congenital factor XII deficiency—A study on 74 subjects from 14 Swiss families. Thrombosis and Haemostasis 65(2): 117–121.
31. Bugge, T.H., Q. Xiao, K.W. Kombrinck, M.J. Flick, K. Holmback, M.J.S. Danton, M.C. Colbert, D.P. Witte, K. Fujikawa, E.W. Davie, et al. 1996. Fatal embryonic bleeding events in mice lacking tissue factor, the cell- associated initiator of blood coagulation. Proceedings of the National Academy of Sciences of the United States of America 93(13): 6258–6263.
32. Camerer, E., A.B.. Kolstø, and H. Prydz. 1996. Cell biology of tissue factor, the principal initiator of blood coagulation. Thrombosis Research 81(1): 1–41.
33. Morrissey, J.H. 2001. Tissue factor: An enzyme cofactor and a true receptor. Thrombosis and Haemostasis 86(1): 66–74.
34. Heinrich, J., L. Balleisen, H. Schulte, G. Assmann, and J. Van de Loo. 1994. Erratum: Fibrinogen and factor VII in the prediction of coronary risk: Results from the PROCAM study in healthy men (Arteriosclerosis and Thrombosis (1994) 14 (54-59)). Arteriosclerosis and Thrombosis 14(8): 1392.
35. Meade, T.W., S. Mellows, M. Brozovic, G.J. Miller, R.R. Chakrabarti, W.R. North, A.P. Haines, Y. Stirling, J.D. Imeson, and S.G. Thompson. 1986. Haemostatic function and ischaemic heart disease: Principal results of the Northwick Park Heart Study. Lancet 2(8506): 533–537.
36. Scott, C.F., L.D. Silver, A.D. Purdon, and R.W. Colman. 1985. Cleavage of human high molecular weight kininogen by factor XIa in vitro: Effect on structure and function. Journal of Biological Chemistry 260(19): 10856–10863.
37. Asakai, R., D.W. Chung, E.W. Davie, and U. Seligsohn. 1991. Factor XI deficiency in Ashkenazi Jews in Israel. New England Journal of Medicine 325(3): 153–158.
38. Meijers, J.C.M., W.L.H. Tekelenburg, B.N. Bouma, R.M. Bertina, and F.R. Rosendaal. 2000. High levels of coagulation factor XI as a risk factor for venous thrombosis. New England Journal of Medicine 342(10): 696–701.
39. Colman, R.W. 1999. Biologic activities of the contact factors in vivo. Potentiation of hypotension, inflammation, and fibrinolysis, and inhibition of cell adhesion, angiogenesis and thrombosis. Thrombosis and Haemostasis 82(6): 1568–1577.
40. Nesheim, M., D.D. Pittman, A.R. Giles, D.N. Fass, J.H. Wang, D. Slonosky, and R.J. Kaufman. 1991. The effect of plasma von Willebrand factor on the binding of human factor VIII to thrombin-activated human platelets. Journal of Biological Chemistry 266(27): 17815–17820.
41. Hamer, R.J., J.A. Koedam, N.H. Beeser-Visser, and J.J. Sixma. 1987. The effect of thrombin on the complex between factor VIII and von Willebrand factor. European Journal of Biochemistry 167(2): 253–259.
42. Bertina, R.M., B.P.C. Koeleman, T. Koster, F.R. Rosendaal, R.J. Dirven, H. De Ronde, P.A. Van Der Velden, and P.H. Reitsma. 1994. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369(6475): 64–67.
43. Nesheim, M.E., J.B. Taswell, and K.G. Mann. 1979. The contribution of bovine factor V and factor Va to the activity of prothrombinase. Journal of Biological Chemistry 254(21): 10952–10962.
44. Doyle, M.F., and P.E. Haley. 1993. Meizothrombin: active intermediate formed during prothrombinase-catalyzed activation of Prothrombin. Methods in Enzymology 222: 299–312.
45. Bauer, K.A. 1999. Activation markers of coagulation. Bailliere’s Best Practice and Research in Clinical Haematology 12(3): 387–406.
46. Poort, S.R., F.R. Rosendaal, P.H. Reitsma, and R.M. Bertina. 1996. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 88(10): 3698–3703.
47. Brummel, K.E., S.G. Paradis, S. Butenas, and K.G. Mann. 2002. Thrombin functions during tissue factor-induced blood coagulation. Blood 100(1): 148–152.
48. Tulinsky, A. 1996. Molecular interactions of thrombin. Seminars in Thrombosis and Hemostasis 22(2): 117–124.
49. Weisel, J.W. 1986. Fibrin assembly. Lateral aggregation and the role of the two pairs of fibrinopeptides. Biophysical Journal 50(6): 1079–1093.
50. Wojtukiewicz, M.Z., E. Sierko, P. Klement, and J. Rak. 2001. The hemostatic system and angiogenesis in malignancy. Neoplasia 3(5): 371–384.
51. Davie, E.W., K. Fujikawa, and W. Kisiel. 1991. The coagulation cascade: Initiation, maintenance, and regulation. Biochemistry 30(43): 10363–10370.
52. Esmon, C.T. 2000. Regulation of blood coagulation. Biochimica et Biophysica Acta - Protein Structure and Molecular Enzymology 1477(1–2): 349–360.
53. Mann, K.G., K. Brummel-Ziedins, T. Orfeo, and S. Butenas. 2006. Models of blood coagulation. Blood Cells, Molecules, and Diseases 36(2): 108–117.
54. Mann, K.G. 1999. Biochemistry and physiology of blood coagulation. Thrombosis and Haemostasis 82(2): 165–174.
55. Jackson, C.M., and Y. Nemerson. 1980. Blood coagulation. Annual Review of Biochemistry 49(1): 765–811.
56. Zarbock, A., R.K. Polanowska-Grabowska, and K. Ley. 2007. Platelet-neutrophil-interactions: linking hemostasis and inflammation. Blood Reviews 21(2): 99–111.
57. Kenny, L., P. Baker, and F.G. Cunningham. 2009. Platelets, coagulation, and the liver. Chesley’s hypertension in pregnancy, 3rd edn, 335. New York: Elsevier.
58. Mosnier, L.O., P. Buijtenhuijs, P.F. Marx, J.C. Meijers, and B.N. Bouma. 2003. Identification of thrombin activatable fibrinolysis inhibitor (TAFI) in human platelets. Blood 101(12): 4844–4846.
59. Frenette, P.S., R.C. Johnson, R.O. Hynes, and D.D. Wagner. 1995. Platelets roll on stimulated endothelium in vivo: an interaction mediated by endothelial P-selectin. Proceedings of the National Academy of Sciences 92(16): 7450–7454.
60. Frenette, P.S., C. Moyna, D.W. Hartwell, J.B. Lowe, R.O. Hynes, and D.D. Wagner. 1998. Platelet–endothelial interactions in inflamed mesenteric venules. Blood 91(4): 1318–1324.
61. Majerus, P. 1987. Platelets. In The molecular basis of blood diseases, ed. G. Stamatoyannopoulos, A.W. Nienhuis, P. Leder, and P. Majerus. Philadelphia: W.B. Saunders Co.
62. Girma, J.P., D. Meyer, C.L. Verweij, H. Pannekoek, and J.J. Sixma. 1987. Structure–function relationship of human von Willebrand factor. Blood 70(3): 605–611.
63. Ruggeri, Z.M., and T.S. Zimmerman. 1987. Von Willebrand factor and von Willebrand disease. Blood 70(4): 895–904.
64. Lopez, J.A., D.W. Chung, K. Fujikawa, F.S. Hagen, E.W. Davie, and G.J. Roth. 1988. The α and β chains of human platelet glycoprotein Ib are both transmembrane proteins containing a leucine-rich amino acid sequence. Proceedings of the National Academy of Sciences of the United States of America 85(7): 2135–2139.
65. Bennett, J.S., G. Vilaire, and D.B. Cines. 1982. Identification of the fibrinogen receptor on human platelets by photoaffinity labeling. Journal of Biological Chemistry 257(14): 8049–8054.
66. Savage, B., and Z.M. Ruggeri. 1991. Selective recognition of adhesive sites in surface-bound fibrinogen by glycoprotein IIb–IIIa on nonactivated platelets. Journal of Biological Chemistry 266(17): 11227–11233.
67. Varga-Szabo, D., A. Braun, and B. Nieswandt. 2009. Calcium signaling in platelets. Journal of Thrombosis and Haemostasis 7(7): 1057–1066.
68. Bergmeier, W., and L. Stefanini. 2009. Novel molecules in calcium signaling in platelets. Journal of Thrombosis and Haemostasis 7(SUPPL. 1): 187–190.
69. Rink, T., and S. Sage. 1990. Calcium signaling in human platelets. Annual Review of Physiology 52(1): 431–449.
70. Neeves, K., D. Illing, and S. Diamond. 2010. Thrombin flux and wall shear rate regulate fibrin fiber deposition state during polymerization under flow. Biophysical Journal 98(7): 1344–1352.
71. Ferri, F., M. Greco, and M. Rocco. 2001. On the determination of the average molecular weight, radius of gyration, and mass/length ratio of polydisperse solutions of polymerizing rod-like macromolecular monomers by multi-angle static lightscattering. Macromolecular Symposia 162(1): 23–44.
72. Yeromonahos, C., B. Polack, and F. Caton. 2010. Nanostructure of the fibrin clot. Biophysical Journal 99(7): 2018–2027.
73. Yang, Z., J.M. Kollman, L. Pandi, and R.F. Doolittle. 2001. Crystal structure of native chicken fibrinogen at 2.7 Å resolution. Biochemistry 40(42): 12515–12523.
74. Ferry, J.D., and P.R. Morrison. 1947. Preparation and properties of serum and plasma proteins. IX. Human fibrin in the form of an elastic film. Journal of the American Chemical Society 69(2): 400–409.
75. Fowler, W., R. Hantgan, J. Hermans, and H. Erickson. 1981. Structure of the fibrin protofibril. Proceedings of the National Academy of Sciences 78(8): 4872–4876.
76. Clark, R.A. 1996. The molecular and cellular biology of wound repair. New York: Springer.
77. Piechocka, I.K., R.G. Bacabac, M. Potters, F.C. Mackintosh, and G.H. Koenderink. 2010. Structural hierarchy governs fibrin gel mechanics. Biophysical Journal 98(10): 2281–2289.
78. Weisel, J.W. 2004. The mechanical properties of fibrin for basic scientists and clinicians. Biophysical Chemistry 112(2-3 SPEC. ISS): 267–276.
79. Liu, W., L.M. Jawerth, E.A. Sparks, M.R. Falvo, R.R. Hantgan, R. Superfine, S.T. Lord, and M. Guthold. 2006. Fibrin fibers have extraordinary extensibility and elasticity. Science 313(5787): 634.
80. Brown, A.E.X., R.I. Litvinov, D.E. Discher, P.K. Purohit, and J.W. Weisel. 2009. Multiscale mechanics of fibrin polymer: Gel stretching with protein unfolding and loss of water. Science 325(5941): 741–744.
81. Shah, J.V., and P.A. Janmey. 1997. Strain hardening of fibrin gels and plasma clots. Rheologica Acta 36(3): 262–268.
82. Wen, Q., A. Basu, J.P. Winer, A. Yodh, and P.A. Janmey. 2007. Local and global deformations in a strain-stiffening fibrin gel. New Journal of Physics 9(11): 428.
83. Kang, H., Q. Wen, P.A. Janmey, J.X. Tang, E. Conti, and F.C. MacKintosh. 2009. Nonlinear elasticity of stiff filament networks: Strain stiffening, negative normal stress, and filament alignment in fibrin gels. Journal of Physical Chemistry B 113(12): 3799–3805.
84. Roberts, W.W., L. Lorand, and L.F. Mockros. 1973. Viscoelastic properties of fibrin clots. Biorheology 10(1): 29–42.
85. Yao, N.Y., R.J. Larsen, and D.A. Weitz. 2008. Probing nonlinear rheology with inertio-elastic oscillations. Journal of Rheology 52(4): 1013–1025.
86. Janmey, P.A., E.J. Amis, and J.D. Ferry. 1983. Rheology of fibrin clots—6. Stress relaxation, creep, and differential dynamic modulus of fine clots in large shearing deformations. Journal of Rheology 27(2): 135–153.
87. Bale, M.D., and J.D. Ferry. 1988. Strain enhancement of elastic modulus in fine fibrin clots. Thrombosis Research 52(6): 565–572.
88. Gardel, M.L., J.H. Shin, F.C. MacKintosh, L. Mahadevan, P. Matsudaira, and D.A. Weitz. 2004. Elastic behavior of cross-linked and bundled actin networks. Science 304(5675): 1301–1305.
89. Ryan, E.A., L.F. Mockros, J.W. Weisel, and L. Lorand. 1999. Structural origins of fibrin clot rheology. Biophysical Journal 77(5): 2813–2826.
90. Xu, J., Y. Tseng, and D. Wirtz. 2000. Strain hardening of actin filament networks: regulation by the dynamic cross-linking protein α-actinin. Journal of Biological Chemistry 275(46): 35886–35892.
91. Janmey, P.A., M.E. McCormick, S. Rammensee, J.L. Leight, P.C. Georges, and F.C. MacKintosh. 2007. Negative normal stress in semiflexible biopolymer gels. Nature Materials 6(1): 48–51.
92. Hudson, N.E., J.R. Houser, E.T. O’Brien Iii, R.M. Taylor Ii, R. Superfine, S.T. Lord, and M.R. Falvo. 2010. Stiffening of individual fibrin fibers equitably distributes strain and strengthens networks. Biophysical Journal 98(8): 1632–1640.
93. Falvo, M.R., D. Millard, E.T. O’Brien Iii, R. Superfine, and S.T. Lord. 2008. Length of tandem repeats in fibrin’s αC region correlates with fiber extensibility. Journal of Thrombosis and Haemostasis 6(11): 1991–1993.
94. Guthold, M., W. Liu, E.A. Sparks, L.M. Jawerth, L. Peng, M. Falvo, R. Superfine, R.R. Hantgan, and S.T. Lord. 2007. A comparison of the mechanical and structural properties of fibrin fibers with other protein fibers. Cell Biochemistry and Biophysics 49(3): 165–181.
95. Liu, W., C.R. Carlisle, E.A. Sparks, and M. Guthold. 2010. The mechanical properties of single fibrin fibers. Journal of Thrombosis and Haemostasis 8(5): 1030–1036.
96. Storm, C., J.J. Pastore, F.C. MacKintosh, T.C. Lubensky, and P.A. Janmey. 2005. Nonlinear elasticity in biological gels. Nature 435(7039): 191–194.
97. Wolberg, A.S. 2007. Thrombin generation and fibrin clot structure. Blood Reviews 21(3): 131–142.
98. Wolberg, A.S., and R.A. Campbell. 2008. Thrombin generation, fibrin clot formation and hemostasis. Transfusion and Apheresis Science 38(1): 15–23.
99. Müller, I., A. Klocke, M. Alex, M. Kotzsch, T. Luther, E. Morgenstern, S. Zieseniss, S. Zahler, K. Preissner, and B. Engelmann. 2003. Intravascular tissue factor initiates coagulation via circulating microvesicles and platelets. The FASEB Journal 17(3): 476–478.
100. Banner, D.W., A. D’Arcy, C. Chene, F.K. Winkler, A. Guha, W.H. Konigsberg, Y. Nemerson, and D. Kirchhofer. 1996. The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factor. Nature 380(6569): 41–46.
101. Hantgan, R.R., G. Hindriks, R.G. Taylor, J.J. Sixma, and P.G. de Groot. 1990. Glycoprotein Ib, von Willebrand factor, and glycoprotein IIb: IIIa are all involved in platelet adhesion to fibrin in flowing whole blood. Blood 76(2): 345–353.
102. Lages, B., and H.J. Weiss. 1994. Evidence for a role of glycoprotein IIb–IIIa, distinct from its ability to support aggregation, in platelet activation by ionophores in the presence of extracellular divalent cations. Blood 83(9): 2549–2559.
103. Cierniewski, C.S., J.W. Smith, E.F. Plow, and T. Haas. 1994. Characterization of cation-binding sequences in the platelet integrin GPIIb-IIIa (. alpha. IIb. beta. 3) by terbium luminescence. Biochemistry 33(40): 12238–12246.
104. Rivas, G., and J. Gonzalez-Rodriguez. 1991. Calcium binding to human platelet integrin GPIIb/IIIa and to its constituent glycoproteins. Effects of lipids and temperature. The Biochemical Journal 276: 35–40.
105. 2+ channel Orai1 in platelets. Biochemical and Biophysical Research Communications 436(1): 25–30.
106. Curtis, C., K. Brown, R. Credo, R. Domanik, A. Gray, P. Stenberg, and L. Lorand. 1974. Calcium-dependent unmasking of active center cysteine during activation of fibrin stabilizing factor. Biochemistry 13(18): 3774–3780.
107. Lorand, L., A.J. Gray, K. Brown, R.B. Credo, C.G. Curtis, R.A. Domanik, and P. Stenberg. 1974. Dissociation of the subunit structure of fibrin stabilizing factor during activation of the zymogen. Biochemical and Biophysical Research Communications 56(4): 914–922.
108. Kitchens, C.S., and T.F. Newcomb. 1979. Factor XIII. Medicine 58(6): 413–429.
109. Nemerson, Y., and D. Repke. 1985. Tissue factor accelerates the activation of coagulation factor VII: The role of a bifunctional coagulation cofactor. Thrombosis Research 40(3): 351–358.
110. Rao, L., and S.I. Rapaport. 1988. The effect of platelets upon factor Xa-catalyzed activation of factor VII in vitro. Blood 72(2): 396–401.
111. Sakai, T., T. Lund-Hansen, L. Paborsky, A. Pedersen, and W. Kisiel. 1989. Binding of human factors VII and VIIa to a human bladder carcinoma cell line (J82). Implications for the initiation of the extrinsic pathway of blood coagulation. Journal of Biological Chemistry 264(17): 9980–9988.
112. Eaton, D., H. Rodriguez, and G.A. Vehar. 1986. Proteolytic processing of human factor VIII. Correlation of specific cleavages by thrombin, factor Xa, and activated protein C with activation and inactivation of factor VIII coagulant activity. Biochemistry 25(2): 505–512.
113. Di Scipio, R.G., K. Kurachi, and E.W. Davie. 1978. Activation of human factor IX (Christmas factor). Journal of Clinical Investigation 61(6): 1528.
114. Lorand, L., and K. Konishi. 1964. Activation of the fibrin stabilizing factor of plasma by thrombin. Archives of Biochemistry and Biophysics 105(1): 58–67.
115. Naski, M.C., L. Lorand, and J.A. Shafer. 1991. Characterization of the kinetic pathway for fibrin promotion of. alpha.-thrombin-catalyzed activation of plasma factor XIII. Biochemistry 30(4): 934–941.
116. Kisiel, W., W.M. Canfield, L.H. Ericsson, and E.W. Davie. 1977. Anticoagulant properties of bovine plasma protein C following activation by thrombin. Biochemistry 16(26): 5824–5831.
117. Marlar, R.A., A.J. Kleiss, and J.H. Griffin. 1982. Mechanism of action of human activated protein C, a thrombin-dependent anticoagulant enzyme. Blood 59(5): 1067–1072.
118. Vehar, G.A., and E.W. Davie. 1980. Preparation and properties of bovine factor VIII (antihemophilic factor). Biochemistry 19(3): 401–410.
119. Walker, F.J. 1980. Regulation of activated protein C by a new protein. A possible function for bovine protein S. Journal of Biological Chemistry 255(12): 5521–5524.
120. Huntington, J.A. 2008. How Na+ activates thrombin—A review of the functional and structural data. Biological Chemistry 389(8): 1025–1035.
121. Lechtenberg, B.C., S.M.V. Freund, and J.A. Huntington. 2012. An ensemble view of thrombin allostery. Biological Chemistry 393(9): 889–898.
122. De Candia, E. 2012. Mechanisms of platelet activation by thrombin: a short history. Thrombosis Research 129(3): 250–256.
123. Weiss, U. 2008. Inflammation. Nature 454(7203): 427.
124. Medzhitov, R. 2008. Origin and physiological roles of inflammation. Nature 454(7203): 428–435.
125. Feghali, C.A., and T.M. Wright. 1997. Cytokines in acute and chronic inflammation. Frontiers in Bioscience: A Journal and Virtual Library 2: d12–d26.
126. Cicala, C., and G. Cirino. 1998. Linkage between inflammation and coagulation: an update on the molecular basis of the crosstalk. Life Sciences 62(20): 1817–1824.
127. Libby, P., and D.I. Simon. 2001. Inflammation and thrombosis: The clot thickens. Circulation 103(13): 1718–1720.
128. Gasparyan, A. 2010. Platelets in inflammation and thrombosis. Inflammation & Allergy Drug Targets 9(5): 319.
129. Gasparyan, A.Y., L. Ayvazyan, D.P. Mikhailidis, and G.D. Kitas. 2011. Mean platelet volume: a link between thrombosis and inflammation? Current Pharmaceutical Design 17(1): 47–58.
130. Gasparyan, A., A. Sandoo, A. Stavropoulos-Kalinoglou, and G. Kitas. 2010. Mean platelet volume in patients with rheumatoid arthritis: the effect of anti-TNF-alpha therapy. Rheumatology International 30(8): 1125–1129.
131. Gasparyan, A.Y., A. Stavropoulos-Kalinoglou, T.E. Toms, K.M. Douglas, and G.D. Kitas. 2010. Association of mean platelet volume with hypertension in rheumatoid arthritis. Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets-Inflammation & Allergy) 9(1): 45–50.
132. Gawaz, M. 2004. Role of platelets in coronary thrombosis and reperfusion of ischemic myocardium. Cardiovascular Research 61(3): 498–511.
133. Borst, O., P. Münzer, S. Gatidis, E.M. Schmidt, T. Schönberger, E. Schmid, S.T. Towhid, K. Stellos, P. Seizer, A.E. May, et al. 2012. The inflammatory chemokine CXC motif ligand 16 triggers platelet activation and adhesion via CXC motif receptor 6-dependent phosphatidylinositide 3-kinase/akt signaling. Circulation Research 111(10): 1297–1307.
134. Gasparyan, A., A. Stavropoulos-Kalinoglou, D. Mikhailidis, K.J. Douglas, and G. Kitas. 2011. Platelet function in rheumatoid arthritis: arthritic and cardiovascular implications. Rheumatology International 31(2): 153–164.
135. Burstein, S. 1997. Cytokines, platelet production and hemostasis. Platelets 8(2–3): 93–104.
136. Pendurthi, U.R., D. Alok, and L.V.M. Rao. 1997. Binding of factor VIIa to tissue factor induces alterations in gene expression in human fibroblast cells: up-regulation of poly(A) polymerase. Proceedings of the National Academy of Sciences of the United States of America 94(23): 12598–12603.
137. Miller, D.L., R. Yaron, and M.J. Yellin. 1998. CD40L–CD40 interactions regulate endothelial cell surface tissue factor and thrombomodulin expression. Journal of Leukocyte Biology 63(3): 373–379.
138. André, P., K.S. Srinivasa Prasad, C.V. Denis, M. He, J.M. Papalia, R.O. Hynes, D.R. Phillips, and D.D. Wagner. 2002. CD40L stabilizes arterial thrombi by a β3 integrin-dependent mechanism. Nature Medicine 8(3): 247–252.
139. Henn, V., J.R. Slupsky, M. Gräfe, I. Anagnostopoulos, R. Förster, G. Müller-Berghaus, and R.A. Kroczek. 1998. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 391(6667): 591–594.
140. Loppnow, H., R. Bil, S. Hirt, U. Schönbeck, M. Herzberg, K. Werdan, E.T. Rietschel, E. Brandt, and H.D. Flad. 1998. Platelet-derived interleukin-1 induces cytokine production, but not proliferation of human vascular smooth muscle cells. Blood 91(1): 134–141.
141. Opal, S.M., and C.T. Esmon. 2003. Bench-to-bedside review: Functional relationships between coagulation and the innate immune response and their respective roles in the pathogenesis of sepsis. Critical Care 7(1): 23–38.
142. Kuijper, P.H.M., H.I. Gallardo Torres, J.A.M. Van Der Linden, J.W.J. Lammers, J.J. Sixma, L. Koenderman, and J.J. Zwaginga. 1996. Platelet-dependent primary hemostasis promotes selectin- and integrin-mediated neutrophil adhesion to damaged endothelium under flow conditions. Blood 87(8): 3271–3281.
143. Corken, A., S. Russell, J. Dent, S.R. Post, and J. Ware. 2014. Platelet glycoprotein Ib-IX as a regulator of systemic inflammation. Arteriosclerosis, Thrombosis, and Vascular Biology 34(5): 996–1001.
144. Petäjä, J. 2011. Inflammation and coagulation. An overview. Thrombosis Research 127(SUPPL. 2): S34–S37.
145. Tracy, R., and E. Bovill. 1995. Hemostasis and risk of ischemic disease: Epidemiologic evidence with emphasis on the elderly. Acute coronary care in the thrombolytic era. 2nd ed, 27–43. St. Louis: Mosby Year Book.
146. Rauch, U., D. Bonderman, B. Bohrmann, J.J. Badimon, J. Himber, M.A. Riederer, and Y. Nemerson. 2000. Transfer of tissue factor from leukocytes to platelets is mediated by CD15 and tissue factor. Blood 96(1): 170–175.
147. Levi, M., and T. Van Der Poll. 2010. Inflammation and coagulation. Critical Care Medicine 38(SUPPL. 2): S26–S34.
148. Esmon, C.T. 2005. The interactions between inflammation and coagulation. British Journal of Haematology 131(4): 417–430.
149. Bevers, E.M., P. Comfurius, D.W.C. Dekkers, M. Harmsma, and R.F.A. Zwaal. 1998. Transmembrane phospholipid distribution in blood cells: Control mechanisms and pathophysiological significance. Biological Chemistry 379(8–9): 973–986.
150. Sims, P.J., T. Wiedmer, C.T. Esmon, H.J. Weiss, and S.J. Shattil. 1989. Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane. Studies in Scott syndrome: An isolated defect in platelet procoagulant activity. Journal of Biological Chemistry 264(29): 17049–17057.
151. Conway, E.M., and R.D. Rosenberg. 1988. Tumor necrosis factor suppresses transcription of the thrombomodulin gene in endothelial cells. Molecular and Cellular Biology 8(12): 5588–5592.
152. Fukudome, K., and C.T. Esmon. 1994. Identification, cloning, and regulation of a novel endothelial cell protein C/activated protein C receptor. Journal of Biological Chemistry 269(42): 26486–26491.
153. Takano, S., S. Kimura, S. Ohdama, and N. Aoki. 1990. Plasma thrombomodulin in health and diseases. Blood 76(10): 2024–2029.
154. Østerud, B. 1998. Tissue factor expression by monocytes: Regulation and pathophysiological roles. Blood Coagulation and Fibrinolysis 9(SUPPL. 1): S9–S14.
155. Neumann, F.J., N. Marx, M. Gawaz, K. Brand, I. Ott, C. Rokitta, C. Sticherling, C. Meinl, A. May, and A. Schömig. 1997. Induction of cytokine expression in leukocytes by binding of thrombin-stimulated platelets. Circulation 95(10): 2387–2394.
156. Souter, P.J., S. Thomas, A.R. Hubbard, S. Poole, J. Römisch, and E. Gray. 2001. Antithrombin inhibits lipopolysaccharide-induced tissue factor and interleukin-6 production by mononuclear cells, human umbilical vein endothelial cells, and whole blood. Critical Care Medicine 29(1): 134–139.
157. Zwaal, R.F.A., and A.J. Schroit. 1997. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood 89(4): 1121–1132.
158. Levi, M., T. Van Der Poll, and H.R. Büller. 2004. Bidirectional relation between inflammation and coagulation. Circulation 109(22): 2698–2704.
159. Sturn, D.H., N.C. Kaneider, C. Feistritzer, A. Djanani, K. Fukudome, and C.J. Wiedermann. 2003. Expression and function of the endothelial protein C receptor in human neutrophils. Blood 102(4): 1499–1505.
160. Isobe, H., K. Okajima, M. Uchiba, A. Mizutani, N. Harada, A. Nagasaki, and K. Okabe. 2001. Activated protein C prevents endotoxin-induced hypotension in rats by inhibiting excessive production of nitric oxide. Circulation 104(10): 1171–1175.
161. Cheng, T., D. Liu, J.H. Griffin, J.A. Fernández, F. Castellino, E.D. Rosen, K. Fukudome, and B.V. Zlokovic. 2003. Activated protein C blocks p53-mediated apoptosis in ischemic human brain endothelium and is neuroprotective. Nature Medicine 9(3): 338–342.
162. Joyce, D.E., L. Gelbert, A. Ciaccia, B. DeHoff, and B.W. Grinnell. 2001. Gene expression profile of antithrombotic protein C defines new mechanisms modulating inflammation and apoptosis. Journal of Biological Chemistry 276(14): 11199–11203.
163. Oelschläger, C., J. Römisch, A. Staubitz, H. Stauss, B. Leithäuser, H. Tillmanns, and H. Hölschermann. 2002. Antithrombin III inhibits nuclear factor κB activation in human monocytes and vascular endothelial cells. Blood 99(11): 4015–4020.
164. Yasui, H., E.C. Gabazza, S. Tamaki, T. Kobayashi, O. Hataji, H. Yuda, S. Shimizu, K. Suzuki, Y. Adachi, and O. Taguchi. 2001. Intratracheal administration of activated protein C inhibits bleomycin-induced lung fibrosis in the mouse. American Journal of Respiratory and Critical Care Medicine 163(7): 1660–1668.
165. Okajima, K. 2001. Regulation of inflammatory responses by natural anticoagulants. Immunological Reviews 184: 258–274.
166. Thomas, R.H. 2001. Hypercoagulability syndromes. Archives of Internal Medicine 161(20): 2433–2439.
167. Chu, A.J. 2005. Tissue factor mediates inflammation. Archives of Biochemistry and Biophysics 440(2): 123–132.
168. Denko, C.W., and M.W. Whitehouse. 1976. Experimental inflammation induced by naturally occurring microcrystalline calcium salts. The Journal of Rheumatology 3(1): 54–62.
169. Bach, R., and D.B. Rifkin. 1990. Expression of tissue factor procoagulant activity: Regulation by cytosolic calcium. Proceedings of the National Academy of Sciences 87(18): 6995–6999.
170. Palabrica, T., R. Lobb, B.C. Furie, M. Aronovitz, C. Benjamin, Y.-M. Hsu, S.A. Sajer, and B. Furie. 1992. Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets. Nature 359: 848–851.
171. Lorant, D., M. Topham, R. Whatley, R. McEver, T. McIntyre, S. Prescott, and G. Zimmerman. 1993. Inflammatory roles of P-selectin. Journal of Clinical Investigation 92(2): 559.
172. Lorant, D.E., K.D. Patel, T.M. McIntyre, R.P. McEver, S.M. Prescott, and G.A. Zimmerman. 1991. Coexpression of GMP-140 and PAF by endothelium stimulated by histamine or thrombin: A juxtacrine system for adhesion and activation of neutrophils. The Journal of Cell Biology 115(1): 223–234.
173. Mikaelsson, M.E. (1991) The role of calcium in coagulation and anticoagulation. In Coagulation and blood transfusion, eds. Sibinga, C.T.S., Das, P.C., Mannucci, P.M., 26: 29–37. Developments in hematology and immunology. New York: Springer.
174. Pretorius, E. 2007. The role of platelet and fibrin ultrastructure in identifying disease patterns. Pathophysiology of Haemostasis and Thrombosis 36(5): 251–258.
175. Swanepoel, A.C., Lindeque, B.G., Swart, P.J., Abdool, Z., Pretorius, E. (2014) Estrogen causes ultrastructural changes of fibrin networks during the menstrual cycle: A qualitative investigation. Microscopy Research and Technique 77: 594–601.
176. Swanepoel, A.C., Pretorius E. (2015) Ultrastructural analysis of platelets during three phases of pregnancy: A qualitative and quantitative investigation. Hematology 20: 39–47.
177. Cooke, R.D. 1974. Calcium-induced dissociation of human plasma factor XIII and the appearance of catalytic activity. The Biochemical Journal 141: 683–691.
178. Kristiansen, G.K., and M.D. Andersen. 2011. Reversible activation of cellular factor XIII by calcium. Journal of Biological Chemistry 286(11): 9833–9839.
179. Nielsen, V.G., W.Q. Gurley Jr., and T.M. Burch. 2004. The impact of factor XIII on coagulation kinetics and clot strength determined by thrombelastography. Anesthesia and Analgesia 99(1): 120–123.
180. Nielsen, V.G., J.K. Kirklin, H. Hoogendoorn, T.C. Ellis, and W.L. Holman. 2007. Thrombelastographic method to quantify the contribution of factor XIII to coagulation kinetics. Blood Coagulation & Fibrinolysis 18(2): 145–150.
181. Pretorius, E., H.M. Oberholzer, W.J. Van Der Spuy, A.C. Swanepoel, and P. Soma. 2011. Qualitative scanning electron microscopy analysis of fibrin networks and platelet abnormalities in diabetes. Blood Coagulation and Fibrinolysis 22(6): 463–467.
182. Löbner, K., Füchtenbusch, M. (2004) Inflammation and diabetes. MMW Fortschritte der Medizin 146(35–36):32-3, 35-6.
183. Pretorius, E., A.C. Swanepoel, H.M. Oberholzer, W.J. Van Der Spuy, W. Duim, and P.F. Wessels. 2011. A descriptive investigation of the ultrastructure of fibrin networks in thrombo-embolic ischemic stroke. Journal of Thrombosis and Thrombolysis 31(4): 507–513.
184. Jin, R., G. Yang, and G. Li. 2010. Inflammatory mechanisms in ischemic stroke: role of inflammatory cells. Journal of Leukocyte Biology 87(5): 779–789.
185. Pretorius, E., H.M. Oberholzer, W.J. Van Der Spuy, A.C. Swanepoel, and P. Soma. 2012. Scanning electron microscopy of fibrin networks in rheumatoid arthritis: A qualitative analysis. Rheumatology International 32(6): 1611–1615.
186. Gasparyan, A.Y., L. Ayvazyan, E. Pretorius, and G.D. Kitas. 2014. Platelets in rheumatic diseases: Friend or foe? Current Pharmaceutical Design 20(4): 552–566.
187. Epstein, F.H., E.H. Choy, and G.S. Panayi. 2001. Cytokine pathways and joint inflammation in rheumatoid arthritis. New England Journal of Medicine 344(12): 907–916.
188. Pretorius, E., J. Bester, N. Vermeulen, B. Lipinski, G.S. Gericke, and D.B. Kell. 2014. Profound morphological changes in the erythrocytes and fibrin networks of patients with hemochromatosis or with hyperferritinemia, and their normalization by iron chelators and other agents. PLoS ONE 9(1): e85271.
189. Wang, L., E.E. Johnson, H.N. Shi, W.A. Walker, M. Wessling-Resnick, and B.J. Cherayil. 2008. Attenuated inflammatory responses in hemochromatosis reveal a role for iron in the regulation of macrophage cytokine translation. The Journal of Immunology 181(4): 2723–2731.
190. Pretorius, E. 2012. Ultrastructural changes in platelet membranes due to cigarette smoking. Ultrastructural Pathology 36(4): 239–243.
191. Pretorius, E., H.M. Oberholzer, W.J. Van Der Spuy, and J.H. Meiring. 2010. Smoking and coagulation: The sticky fibrin phenomenon. Ultrastructural Pathology 34(4): 236–239.
192. De Maat, M.P.M., and C. Kluft. 2002. The association between inflammation markers, coronary artery disease and smoking. Vascular Pharmacology 39(3): 137–139.
193. Malerba, M., and P. Montuschi. 2012. Non-invasive biomarkers of lung inflammation in smoking subjects. Current Medicinal Chemistry 19(2): 187–196.
194. Van Der Vaart, H., D.S. Postma, W. Timens, and N.H.T. Ten Hacken. 2004. Acute effects of cigarette smoke on inflammation and oxidative stress: A review. Thorax 59(8): 713–721.
195. Pretorius, E., du Plooy, J., Soma, P., Gasparyan, AY. (2014) An ultrastructural analysis of platelets, erythrocytes, white blood cells, and fibrin network in systemic lupus erythematosus. Rheumatology International 34: 1005–1009.
196. Belmont, H.M., S.B. Abramson, and J.T. Lie. 1996. Pathology and pathogenesis of vascular injury in systemic lupus erythematosus Interactions of inflammatory cells and activated endothelium. Arthritis and Rheumatism 39(1): 9–22.
197. Pretorius, E., and H.M. Oberholzer. 2009. Ultrastructural changes of platelets and fibrin networks in human asthma: A qualitative case study. Blood Coagulation and Fibrinolysis 20(2): 146–149.
198. Kay, A.B.. 1991. Asthma and inflammation. Journal of Allergy and Clinical Immunology 87(5): 893–910.